Available Drugs for testing

Our catalog includes over 100 FDA-approved drugs.

Select a drug category to view the respective available therapies for testing

    • Azacitidine

    • Blinatumomab

    • Cladribine

    • Clofarabine

    • Crenolanib

    • Cytarabine

    • Cytarabine+ Mitoxantrone

    • Daunorubicin

    • Decitabine

    • Gilterinib

    • Idarubicin

    • Idasanutlin

    • Midostaurin

    • Mitoxantrone

    • Nilotinib

    • Panobinostat

    • Quizartinib

    • RG-7112

    • Siremadlin

    • Sorafenib

    • Venetoclax

    • 4-OH Tamoxifen

    • Bleomycin HCl

    • Carboplatin

    • Cisplatin

    • Cycloheximide

    • Cyclophosphamide

    • Docetaxel

    • Doxorubicin

    • Epirubicin

    • Etoposide

    • Fluorouracil (5-FU)

    • FOLFIRI

    • FOLFOX

    • Gemcitabine

    • Ifosfamide

    • Irinotecan (SN-38)

    • Ixabepilone

    • Methotrexate

    • Oxaliplatin

    • Paclitaxel

    • Pemetrexed

    • Tipiracil

    • Vinorelbine

    • Vismodegib

    • Binimetinib

    • Bortezomib

    • Carfilzomib

    • Dabrafenib

    • Daratumumab

    • Dexamethasone

    • Encorafenib

    • Etoposide

    • Ixazomib

    • Lenalidomide

    • Cyclophosphamide

    • Melphalan

    • MMAF

    • Pomalidomide

    • Regorafenib

    • Selinexor

    • Trametinib

    • Venetoclax

    • Abemaciclib

    • Afatinib

    • Alectinib

    • Alpelisib

    • Axitinib

    • Bendamustine HCl

    • Bosutinib

    • Brigatinib

    • Cabazitaxel

    • Cabozantinib

    • Capmatinib

    • Ceritinib

    • Cobimetinib

    • Crizotinib

    • Dabrafenib

    • Dacomitinib

    • Dasatinib

    • Encorafenib

    • Entrectinib

    • Erlotinib

    • Everolimus

    • Gefitinib

    • Imatinib

    • Lapatinib

    • Larotrectinib

    • Mitomycin

    • Mobocertinib

    • Neratinib

    • Olaparib

    • Osimertinib

    • Panobinostat

    • Pazopanib

    • Ponatinib

    • Ribociclib

    • Sunitinib

    • Talazoparib

    • Topotecan

    • Trametinib

    • Vandetanib

    • Vemurafenib

    • Vinblastine

    • Vincristine Sulfate

NOTES AND ADDITIONAL INFORMATION:

  1. Cyclophosphamide requires metabolic activation in vivo. In order to test for cell sensitivity in vitro, we use mafosfamide (aka maphosphamide), a cyclophosphamide analog that spontaneously hydrolyzes to the same active products.

  2. FOLFIRINOX is a combination of folinic acid (Leucovorin) “FOL”, fluorouracil (5-FU) “F”, irinotecan (Camptosar) “IRIN”, and oxaliplatin (Eloxatin) "OX".

  3. FOLFOX is a combination of folinic acid (Leucovorin) "FOL", fluorouracil (5-FU) "F", and oxaliplatin (Eloxatin) "OX".

  4. Testing the IMiDs (including lenalidomide and pomalidomide) as monotherapies do not reliably produce mass response results that predict patient outcomes. 

 

You can order up to 20 FDA-approved drugs of your choice with Travera RTS™.

Alternatively, Travera provides predetermined drug panels for each supported indication with Travera EarlyAccess™.

Limitations of the Early Access Program

The Travera EarlyAccess™ and the Travera RTS™ tests are available as a part of a temporary Early Access Program.
We want to be fully transparent about the following limitations and potential risks:

  • We do not receive enough live cells and can’t test the entire panel of 20 drugs.

  • Shipping delays result in the death of cancer cells. The sample would be rejected.

  • We have limited clinical evidence to date (all preliminary clinical studies have been promising and the evidence is growing)

  • Our catalog is growing but does not yet include all FDA-approved cancer drugs.

  • We do not address sarcomas and lymphomas yet.

  • We do not test pediatric cancers (for patients under 18 years old).